Six-month outcome following a relapse of schizophrenia

References

• Lindstrom E, Jonsson D, von Knorring L. Health economic aspects on the treatment of schizophrenia. Critical Issues in the Treatment of Schizophrenia, N Brunello, G Racagni, J Mendlewicz. Karger, Basel 1995; 182–192
   Google Scholar
• Rupp A, Keith SJ. The costs of schizophrenia. Assessing the burden. Psychiatric Clinics of North America 1993; 16: 413–423
   PubMed Web of Science ®Google Scholar
• Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Jr., Davis JM, Lewis DA. Predicting the ‘revolving door’ phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry 1995; 152: 856–861
   PubMed Web of Science ®Google Scholar
• Owen RR, Fischer EP, Booth BM, Cuffel BJ. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services 1996; 47: 853–858
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry 1997; 154: 1–63
   Web of Science ®Google Scholar
• McGlashan TH, Fenton WS. Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophrenia Bulletin 1993; 19: 71–84
   PubMed Web of Science ®Google Scholar
• Kelley ME, Gilbertson M, Mouton A, van K, Ammen DP. Deterioration in premorbid functioning in schizophrenia: A developmental model of negative symptoms in drug-free patients. American Journal of Psychiatry 1992; 149: 1543–1548
   PubMed Web of Science ®Google Scholar
• Bilder RM, Lipschutz Broch L, Reiter G, Geisler SH, Mayerhoff DI, Lieberman JA. Intellectual deficits in first-episode schizophrenia: Evidence for progressive deterioration. Schizophrenia Bulletin 1992; 18: 437–448
   PubMed Web of Science ®Google Scholar
• Carone BJ, Harrow M, Westermeyer JF. Posthospital course and outcome in schizophrenia. Archives of General Psychiatry 1991; 48: 247–253
   PubMed Web of Science ®Google Scholar
• Lehman AF. Evaluating outcomes of treatments for persons with psychotic disorders. Journal of Clinical Psychiatry 1996; 57(Suppl. 11)61–67
   PubMed Web of Science ®Google Scholar
• Chandler D, Meisel J, Hu TW, McGowen M, Madison K. Client outcomes in a three-year controlled study of an integrated service agency model. Psychiatric Services 1996; 47: 1337–1343
   PubMed Web of Science ®Google Scholar
• Wolff N, Helminiak TW, Morse GA, Calsyn RJ, Klinkenberg WD, Trusty ML. Cost-effectiveness evaluation of three approaches to case management for homeless mentally ill clients. American Journal of Psychiatry 1997; 154: 341–348
   PubMed Web of Science ®Google Scholar
• Barry KL, Fleming MF, Greenley J, Widlak P, Kropp S, McKee D. Assessment of alcohol and other drug disorders in the seriously mentally ill. Schizophrenia Bulletin 1995; 21: 313–321
   PubMed Web of Science ®Google Scholar
• Davis JM. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 1976; 33: 858–861
   PubMed Web of Science ®Google Scholar
• Gupta S, Hendricks S, Kenkel AM, Bhatia SC, Haffke EA. Relapse in schizophrenia: Is there a relationship to substance abuse?. Schizophrenia Research 1996; 20: 153–156
   PubMed Web of Science ®Google Scholar
• Kozaric-Kovacic D, Folnegovic-Smalc V, Folnegovic Z, Maruic A. Influence of alcoholism on the prognosis of schizophrenic patients. Journal of Studies in Alcohol 1995; 56: 622–627
   PubMed Web of Science ®Google Scholar
• Menezes PR, Johnson S, Thornicroft G, et al. Drug and alcohol problems among individuals with severe mental illness in south London. British Journal of Psychiatry 1996; 168: 612–619
   PubMed Web of Science ®Google Scholar
• Narrow WE, Regier DA, Rae DS, Manderscheid RW, Locke BZ. Use of services by persons with mental and addictive disorders. Findings from the National Institute of Mental Health Epidemiologic Catchment Area Program. Archives of General Psychiatry 1993; 50: 95–107
   PubMed Web of Science ®Google Scholar
• D'Mello DA, Boltz MK, Msibi B. Relationship between concurrent substance abuse in psychiatric patients and neuroleptic dosage. American Journal of Drug and Alcohol Abuse 1995; 21: 257–265
   PubMed Web of Science ®Google Scholar
• Ruscher SM, de Wit R, Mazmanian D. Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatric Services 1997; 48: 82–85
   PubMed Web of Science ®Google Scholar
• Weiden P, Rapkin B, Mott T, et al. Rating of Medication Influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin 1994; 20: 297–310
   PubMed Web of Science ®Google Scholar
• Davis JM, Kane JM, Marder SR, et al. Dose response of prophylactic antipsychotics. Journal of Clinical Psychiatry 1993; 54(Suppl)24–30
   PubMed Web of Science ®Google Scholar
• Smith J, Hucker S. Schizophrenia and substance abuse. British Journal of Psychiatry 1994; 164: 13–21
   Google Scholar
• Drake RE, McLaughlin P, Pepper P, Minkoff K. Dual diagnosis of major mental illness and substance disorder: An overview. New Directions for Mental Health Services 1991; 50: 3–12
   PubMedGoogle Scholar
• Drake RE, Osher FC, Wallach MA. Alcohol use and abuse in schizophrenia. A prospective community study. Journal of Nervous and Mental Disease 1989; 177: 408–414
   PubMed Web of Science ®Google Scholar
• Cuffel BJ, Chase P. Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study. Journal of Nervous and Mental Disease 1994; 182: 342–348
   PubMed Web of Science ®Google Scholar
• Gilbert PL, Harris MJ, McAdams LA, Jeste DV. Neuroleptic withdrawal in schizophrenic patients: A review of the literature. Archives of General Psychiatry 1995; 52: 173–188
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Viguera AC. Neuroleptic withdrawl in schizophrenic patients. Archives of General Psychiatry 1995; 52: 189–192
   PubMed Web of Science ®Google Scholar
• Ereshefsky L. Pharmacokinetics and drug interactions: Update for new antipsychotics. Journal of Clinical Psychiatry 1996; 57(Suppl. II)12–25
   PubMed Web of Science ®Google Scholar
• Johnson S. Dual diagnosis of severe mental illness and substance misuse: A case for specialist services?. British Journal of Psychiatry 1997; 171: 205–208
   PubMed Web of Science ®Google Scholar
• Osher FC, Dixon LB. Housing for persons with co-occurring mental and addictive disorders. New Directions in Mental Health Services 1996; 70: 53–64
   Google Scholar
• Osher FC, Kofoed LL. Treatment of patients with psychiatric and psychoactive substance abuse disorders. Hospital and Community Psychiatry 1989; 40: 1025–1030
   PubMedGoogle Scholar
• Lachance KR, Santos AB. Modifying the PACT model: Preserving critical elements. Psychiatric Services 1995; 46: 601–604
   PubMed Web of Science ®Google Scholar